Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.
about
Inhibition of regulated cell death by cell-penetrating peptidesImaging of prehospital stroke therapeuticsNovel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical TreatmentsThe NMDA receptor complex: a multifunctional machine at the glutamatergic synapseExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSDisrupting GluA2-GAPDH Interaction Affects Axon and Dendrite DevelopmentTargeting protein-protein interactions with trimeric ligands: high affinity inhibitors of the MAGUK protein familyEfficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species.Mitochondrial dysfunction induced by nuclear poly(ADP-ribose) polymerase-1: a treatable cause of cell death in stroke.Stroke after aortic valve surgery: results from a prospective cohort.In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury.Restoring neuroprotection through a new preclinical paradigm: translational success for NA-1 in stroke therapyBlood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke.Dehydroascorbic Acid Attenuates Ischemic Brain Edema and Neurotoxicity in Cerebral Ischemia: An in vivo Study.Rigidified clicked dimeric ligands for studying the dynamics of the PDZ1-2 supramodule of PSD-95.Tat-NR2B9c prevents excitotoxic neuronal superoxide production.Remote ischemic preconditioning in the prevention of ischemic brain damage during intracranial aneurysm treatment (RIPAT): study protocol for a randomized controlled trial.Should CT Angiography be a Routine Component of Acute Stroke Imaging?Ocular Dominance Plasticity after Stroke Was Preserved in PSD-95 Knockout Mice.Ligand binding to the PDZ domains of postsynaptic density protein 95.Cerebral protection during neurosurgery and stroke.Clinical trials in cardiac arrest and subarachnoid hemorrhage: lessons from the past and ideas for the future.Neurorestoration after stroke.Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemiaNeuroprotection in stroke: past, present, and future.Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation.Efficient Binding of the NOS1AP C-Terminus to the nNOS PDZ Pocket Requires the Concerted Action of the PDZ Ligand Motif, the Internal ExF Site and Structural Integrity of an Independent ElementInfluence of GluN2 subunit identity on NMDA receptor function.Emerging issues in acute ischemic stroke.Antiplatelet testing in neurointervention: we cannot ignore the signs.Stroke in 2013: disappointments and advances in acute stroke intervention.Proton-sensitive cation channels and ion exchangers in ischemic brain injury: new therapeutic targets for stroke?Controversies in the anesthetic management of intraoperative rupture of intracranial aneurysmClinical trials in acute ischemic stroke.Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling.Pannexin channels and ischaemia.Neuroprotection in stroke: the importance of collaboration and reproducibility.Prehospital stroke care: telemedicine, thrombolysis and neuroprotection.Effects of Dimeric PSD-95 Inhibition on Excitotoxic Cell Death and Outcome After Controlled Cortical Impact in Rats.
P2860
Q26751423-F5779B5C-0DE3-40CD-8FD4-A18505BB4D87Q26797275-E4EE70C9-513C-41FA-A46D-121F45A5BFD8Q26800178-2BE8042D-717B-4556-90A0-E0D274734A33Q26992363-293F37B5-9612-4B11-B21C-772E1A113BE3Q27021649-9E96159A-5127-4911-8155-6A4BCFA1D21CQ27322805-1E432D31-1C89-4014-924E-75B54651A3D4Q28543254-9093E154-5D74-4167-83C1-23C90CF0CE49Q31031847-599AAAC2-02CB-414E-91C4-6AC97BC6EFFFQ33667395-CAAF37E1-0055-406C-A942-9174BF64EFFEQ33707034-970D3174-09F3-4DE9-8B77-A8D4FA2FE0A2Q33724954-2E1697AE-39EE-4E1F-BF7C-66880407CF1BQ33862360-E8881A78-897A-4790-9569-AAF9758A1CFDQ33863549-712038C1-5462-4577-9BD9-3C0757888107Q34802636-EEF4E6BA-F931-40CE-ABAD-07C1E1567184Q35187253-6E7E90A8-D486-4075-948B-EB29CFFF5F40Q35434851-6C596D04-ECF6-4070-B877-7A9AE056030CQ35572811-C01AB8C0-B2A0-4793-AB28-775C7EE47FB2Q35881011-054B1F6B-B289-47E4-B459-C52D9DB88258Q35932824-9D8E8BFF-5967-4B6D-A3C9-9E05D750D31FQ35941395-A38C2BB8-EDCE-45FA-ACF4-885772E0BDD9Q35945639-ED1B476F-A07B-47FA-9220-C3122EC37841Q36328100-855119D7-0B85-4BDC-8DE0-603FEDE1C34FQ36711857-57B08CF0-BA5C-4709-840F-D9F095FB78AEQ37028288-3868DFA7-DEDA-4B40-B709-2868E592F999Q37352120-7C4F25FF-89BE-49D9-AF7B-522098B86082Q37571562-37434B42-800E-4C5B-A03B-4640D937114FQ37607614-143D191A-0FBB-4C23-8D8D-2E1BC744AEA4Q37699516-E539A7F0-E662-4BDC-AC1E-F15AA58AC4ABQ38078685-92DBBB24-2000-428E-B09F-10E98493F180Q38099794-2A9D308A-EAEE-4D9A-8762-44CEEAB023A7Q38114045-9AE40083-0349-4C85-B2D2-C55777E14D14Q38176183-009FEC4C-C3F2-4CEE-BB9C-8FDC25C05546Q38182201-7E4EDFB3-D065-4AD7-8352-10EABF60ACEBQ38203881-92FADEA4-8849-44E5-85A1-C3A310D03238Q38243696-9A43C9E6-C62D-4F28-BF9C-FEB55EBDCA76Q38249173-FE0B681C-A46E-484B-AC99-109F38478BDAQ38266684-5112A6E1-3F37-4512-A16D-4DB394F50D2CQ38370165-E15E3D42-0199-4727-AB16-7835D6AAA88EQ38537388-3E8A007B-A7EA-43A1-9517-151E7F66256FQ38638933-969B60E4-4E7D-4D8C-97EC-9F5C31D29CE5
P2860
Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Safety and efficacy of NA-1 in ...... ind, placebo-controlled trial.
@en
Safety and efficacy of NA-1 in ...... ind, placebo-controlled trial.
@nl
type
label
Safety and efficacy of NA-1 in ...... ind, placebo-controlled trial.
@en
Safety and efficacy of NA-1 in ...... ind, placebo-controlled trial.
@nl
prefLabel
Safety and efficacy of NA-1 in ...... ind, placebo-controlled trial.
@en
Safety and efficacy of NA-1 in ...... ind, placebo-controlled trial.
@nl
P2093
P50
P1433
P1476
Safety and efficacy of NA-1 in ...... lind, placebo-controlled trial
@en
P2093
Andrew M Demchuk
Cameron McDougall
Cheemun Lum
David Garman
ENACT trial investigators
Frank L Silver
Geneviève Milot
Ian Fleetwood
John H Wong
Julie Bishop
P304
P356
10.1016/S1474-4422(12)70225-9
P577
2012-10-08T00:00:00Z